ciprofloxacin has been researched along with ibuprofen in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.96) | 18.2507 |
| 2000's | 7 (13.73) | 29.6817 |
| 2010's | 27 (52.94) | 24.3611 |
| 2020's | 16 (31.37) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Alla, M; Balasubramanian, S; Bommena, VR; Bommineni, MR; Mandha, SR; Siliveri, S | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Capito, JE; El-Manawaty, MA; George, RF; Girgis, AS; Panda, SS; Salman, A; Samir, A; Thomas, SJ | 1 |
| Lindahl, G; Perman, E | 1 |
| Castle, DM; Johnson, DJ; Lam, M; Mabury, SA; Richards, SM; Sibley, PK; Solomon, KR; Wilson, CJ | 1 |
| Cañada-Cañada, F; Espinosa-Mansilla, A; González Gómez, D; Muñoz de la Peña, A | 1 |
| Bleidorn, J; Gágyor, I; Hummers-Pradier, E; Kochen, MM; Wegscheider, K | 2 |
| Bucuk, M; Crnić-Martinović, M; Perković, O; Poljak, I; Ristić, S; Sepcić, J; Sepcić, K; Sepić-Grahovac, D; Troselj-Vukić, B; Turel, I | 1 |
| Diaz-Rivera, D; He, Z; Pee, GY; Weavers, LK; Xiao, R | 1 |
| Jiang, JQ; Zhou, Z | 1 |
| Geiger, E; Hornek-Gausterer, R; Saçan, MT | 1 |
| Chen, X; Xing, Y; Zhuang, J | 1 |
| Bartkevics, V; Davids, M; Fridmanis, D; Gudra, D; Muter, O; Radovica-Spalvina, I | 1 |
| Baldini, M; Benedini, LA; Laiuppa, JA; Messina, PV; Placente, D; Santillán, GE | 1 |
| Arshad, N; Channar, PA; Farooqi, SI; Javed, A; Larik, FA; Perveen, F; Saeed, A | 1 |
| Bridgeman, PJ; Jawaro, T; Mele, J; Wei, G | 1 |
| Benedini, L; Messina, P; Placente, D; Ruso, J | 1 |
| Pawar, V; Srivastava, R | 1 |
| Azad, MA; Brancazio, D; Eccles, ME; Grela, E; Hammersmith, G; Klee, DM; Myerson, AS; Osorio, JG; Rapp, K; Sloan, R; Wang, A | 1 |
| Albayrak, M; Bayır, Y; Karataş, E; Uluköylü, E | 1 |
| Abd Elsalam, EA; Abdelaziz, MM; El-Sherbiny, IM; Khalil, IA; Shabaiek, HF | 1 |
| Alves, MM; Gomes, JC; Martins, G; Pereira, L; Salvador, AF; Silva, AR | 1 |
| Dos Reis, LG; Sencadas, V; Silva, DM; Tobin, MJ; Traini, D; Vongsvivut, J | 1 |
| Abril, N; Bello-López, MÁ; Blasco, J; Fernández-Cisnal, R; Fernández-Torres, R; Hampel, M; Kazakova, J; Montilla-López, A; Trombini, C | 1 |
| Abioye, A; Adepoju-Bello, AA; Naqvi, M; Pattni, D | 1 |
| Boncz, MÁ; López-Serna, R; Muñoz, R; Ruas, G; Scarcelli, PG; Serejo, ML | 1 |
| Ghanbari, F; Khodaparast, S; Zamani, H | 1 |
| Akash, S; Elakiya, BT; Govarthanan, M; Rajamohan, N; Sivaprakash, B | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Alsubih, M; Balakrishnan, D; El Morabet, R; Khan, AR; Khan, NA; Khan, RA; Khan, S; Khoo, KS; Mubashir, M | 1 |
| Miyagawa, A; Nagatomo, S; Nakatani, K; Oshiyama, K | 1 |
| Ali, MEM; Gomaa, E; Mohammed, R; Mohsen, M | 1 |
| Akinsete, SJ; Egbeyemi, MM; Ewemoje, TA; Lateef, SA; Omobowale, MO | 1 |
| Bouwman, H; Kümmerer, K; Kylin, H; Nantaba, F; Palm, WU; Wasswa, J | 1 |
| Ahmed-Anwar, AA; Farghali, AA; Hassouna, MEM; Mahmoud, R; Mohamed, MA | 1 |
2 review(s) available for ciprofloxacin and ibuprofen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Remediation of pharmaceutical pollutants using graphene-based materials - A review on operating conditions, mechanism and toxicology.
Topics: Adsorption; Ciprofloxacin; Environmental Pollutants; Graphite; Ibuprofen; Pharmaceutical Preparations; Water Pollutants, Chemical | 2022 |
3 trial(s) available for ciprofloxacin and ibuprofen
| Article | Year |
|---|---|
Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Double-Blind Method; Female; Germany; Humans; Ibuprofen; Middle Aged; Pilot Projects; Treatment Outcome; Urinary Tract Infections; Young Adult | 2010 |
Practices, patients and (im)perfect data--feasibility of a randomised controlled clinical drug trial in German general practices.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Attitude of Health Personnel; Ciprofloxacin; Cooperative Behavior; Double-Blind Method; Feasibility Studies; Female; General Practice; Germany; Humans; Ibuprofen; Interdisciplinary Communication; Male; Middle Aged; Patient Selection; Risk Assessment; Sample Size; Therapeutic Equivalency; Treatment Outcome; Urinary Tract Infections; Workload; Young Adult | 2011 |
Effect of Calcium Hydroxide Alone or in Combination with Ibuprofen and Ciprofloxacin on Nuclear Factor Kappa B Ligand and Osteoprotegerin Level in Periapical Lesions: A Randomized Controlled Clinical Study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium Hydroxide; Ciprofloxacin; Humans; Ibuprofen; NF-kappa B; Osteoprotegerin; Periapical Diseases; RANK Ligand | 2019 |
46 other study(ies) available for ciprofloxacin and ibuprofen
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Eco-friendly synthesis and biological evaluation of substituted pyrano[2,3-c]pyrazoles.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Proliferation; Crystallography, X-Ray; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Conformation; Pyrazoles; Rats | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates.
Topics: Amino Acids; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Carrageenan; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Edema; Mice; Microbial Sensitivity Tests; Molecular Structure; Pain; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Rats; Salmonella typhi; Spleen; Staphylococcus aureus; Streptococcus pyogenes; Ulcer | 2020 |
[Influenza vaccine caused problems in joints. Compensation from the drug insurance authority].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Ciprofloxacin; Female; Humans; Ibuprofen; Influenza Vaccines; Male; Middle Aged | 1999 |
Effects of pharmaceutical mixtures in aquatic microcosms.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Araceae; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Ecosystem; Fishes; Fluoxetine; Food Chain; Ibuprofen; Multivariate Analysis; Phytoplankton; Population Dynamics; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Water Microbiology; Water Pollutants, Chemical; Zooplankton | 2004 |
HPLC determination of ciprofloxacin, cloxacillin, and ibuprofen drugs in human urine samples.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Buffers; Chromatography, High Pressure Liquid; Ciprofloxacin; Cloxacillin; Humans; Hydrogen-Ion Concentration; Ibuprofen; Reference Standards | 2006 |
Drug-induced aseptic meningitis, sensorineural hearing loss and vestibulopaty.
Topics: Ciprofloxacin; Drug Interactions; Female; Hearing Loss, Sensorineural; Humans; Ibuprofen; Meningitis, Aseptic; Middle Aged; Ranitidine; Tinnitus; Vestibular Neuronitis | 2010 |
Sonochemical degradation of ciprofloxacin and ibuprofen in the presence of matrix organic compounds.
Topics: Benzopyrans; Ciprofloxacin; Ibuprofen; Phthalic Acids; Sonication | 2014 |
Reaction kinetics and oxidation products formation in the degradation of ciprofloxacin and ibuprofen by ferrate(VI).
Topics: Ciprofloxacin; Hydrogen-Ion Concentration; Ibuprofen; Iron; Kinetics; Oxidants; Oxidation-Reduction; Water Pollutants, Chemical; Water Purification | 2015 |
Single and mixture toxicity of pharmaceuticals and chlorophenols to freshwater algae Chlorella vulgaris.
Topics: Chlorella vulgaris; Chlorophenols; Ciprofloxacin; Fresh Water; Ibuprofen; Inhibitory Concentration 50; Water Pollutants, Chemical | 2016 |
Colloid-Mediated Transport of Pharmaceutical and Personal Care Products through Porous Media.
Topics: Adsorption; Ciprofloxacin; Colloids; Ibuprofen; Ions; Pharmaceutical Preparations; Porosity; Soil; Soil Pollutants; Tetracycline; Water Movements | 2016 |
The effects of ibuprofen on activated sludge: Shift in bacterial community structure and resistance to ciprofloxacin.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Biological Oxygen Demand Analysis; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Ibuprofen; RNA, Ribosomal, 16S; Sewage; Water Pollutants, Chemical | 2017 |
Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Survival; Cells, Cultured; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Durapatite; Escherichia coli; Ibuprofen; Lipids; Membranes, Artificial; Nanoparticles; Osteoblasts; Particle Size; Pseudomonas aeruginosa; Rats, Wistar; Staphylococcus aureus | 2018 |
Synthesis, theoretical, spectroscopic and electrochemical DNA binding investigations of 1, 3, 4-thiadiazole derivatives of ibuprofen and ciprofloxacin: Cancer cell line studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Ciprofloxacin; DNA; Humans; Hydrogen-Ion Concentration; Ibuprofen; Intercalating Agents; Kinetics; Molecular Docking Simulation; Spectrum Analysis; Thermodynamics; Thiadiazoles | 2018 |
Descriptive study of drug-drug interactions attributed to prescriptions written upon discharge from the emergency department.
Topics: Acetaminophen; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Analgesics; Ciprofloxacin; Drug Combinations; Drug Interactions; Emergency Service, Hospital; Female; Glucocorticoids; Humans; Ibuprofen; Male; Oxycodone; Patient Discharge; Prednisone; Retrospective Studies | 2019 |
Adsorption/desorption study of antibiotic and anti-inflammatory drugs onto bioactive hydroxyapatite nano-rods.
Topics: Adsorption; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Durapatite; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Nanotubes; Osmolar Concentration; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2019 |
Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Line; Cell Survival; Chitosan; Chronic Disease; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Erythrocytes; Humans; Ibuprofen; Mice; Osteomyelitis; Polyesters; Staphylococcus aureus | 2019 |
On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
Topics: Ciprofloxacin; Diazepam; Diphenhydramine; Doxycycline; Drug Compounding; Drug Liberation; Excipients; Ibuprofen; Particle Size; Powders; Solubility; Solvents; Tablets | 2019 |
Fortified hyperbranched PEGylated chitosan-based nano-in-micro composites for treatment of multiple bacterial infections.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bentonite; Chitosan; Ciprofloxacin; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Ibuprofen; Metal Nanoparticles; Microspheres; Nanocomposites; Polyamines; Polyethylene Glycols; Silver; Solubility | 2020 |
Ciprofloxacin, diclofenac, ibuprofen and 17α-ethinylestradiol differentially affect the activity of acetogens and methanogens in anaerobic communities.
Topics: Anaerobiosis; Bacteria; Ciprofloxacin; Diclofenac; Ethinyl Estradiol; Ibuprofen; Microbiota; Wastewater; Water Pollutants, Chemical | 2020 |
Co-delivery of inhalable therapies: Controlling active ingredients spatial distribution and temporal release.
Topics: Administration, Inhalation; Ciprofloxacin; Humans; Ibuprofen; Particle Size; Polymers; Quality of Life | 2021 |
Assessment of pharmaceutical mixture (ibuprofen, ciprofloxacin and flumequine) effects to the crayfish Procambarus clarkii: A multilevel analysis (biochemical, transcriptional and proteomic approaches).
Topics: Animals; Astacoidea; Ciprofloxacin; Fluoroquinolones; Hepatopancreas; Ibuprofen; Multilevel Analysis; Oxidative Stress; Pharmaceutical Preparations; Proteomics; Water Pollutants, Chemical | 2021 |
Non-intuitive Behavior of Polymer-Ciprofloxacin Nanoconjugate Suspensions: a Tool for Flexible Oral Drug Delivery.
Topics: Ciprofloxacin; Drug Carriers; Ibuprofen; Nanoconjugates; Polymers; Suspensions | 2021 |
Influence of the hydraulic retention time on the removal of emerging contaminants in an anoxic-aerobic algal-bacterial photobioreactor coupled with anaerobic digestion.
Topics: Acetaminophen; Anaerobiosis; Bacteria, Aerobic; Bioreactors; Ciprofloxacin; Dexamethasone; Enrofloxacin; Ibuprofen; Naproxen; Photobioreactors; Progesterone; Sewage; Sulfamethoxazole; Tetracyclines; Trimethoprim; Tylosin; Waste Disposal, Fluid | 2022 |
Evaluation of the effect of ibuprofen in combination with ciprofloxacin on the virulence-associated traits, and efflux pump genes of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Humans; Ibuprofen; Membrane Transport Proteins; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Comparison of constructed wetland performance coupled with aeration and tubesettler for pharmaceutical compound removal from hospital wastewater.
Topics: Acetaminophen; Animals; Carbamazepine; Ciprofloxacin; Erythromycin; Hospitals; Ibuprofen; Lorazepam; Pharmaceutical Preparations; Simvastatin; Waste Disposal, Fluid; Wastewater; Wetlands | 2023 |
Semi-quantification of the binding constant based on bond breaking in a combined acoustic-gravitational field.
Topics: Acoustics; Ciprofloxacin; Glycogen; Ibuprofen; Mannans; Naproxen; Serum Albumin, Bovine | 2022 |
Copper sulfide and zinc oxide hybrid nanocomposite for wastewater decontamination of pharmaceuticals and pesticides.
Topics: Acetates; Ceftriaxone; Ciprofloxacin; Copper; Decontamination; Ibuprofen; Nanocomposites; Pesticides; Pharmaceutical Preparations; Sulfides; Wastewater; Zinc Oxide | 2022 |
Health risk assessment for uptake and accumulation of pharmaceuticals in jute mallow (Corchorus olitorius) irrigated with treated hospital wastewater.
Topics: Acetaminophen; Agricultural Irrigation; Anti-Bacterial Agents; Ciprofloxacin; Corchorus; Diclofenac; Environmental Monitoring; Humans; Ibuprofen; Pharmaceutical Preparations; Risk Assessment; Soil; Soil Pollutants; Sulfamethoxazole; Tetracyclines; Wastewater; Water | 2023 |
Spatial trends and ecotoxic risk assessment of selected pharmaceuticals in sediments from Lake Victoria, Uganda, East Africa.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Ecosystem; Environmental Monitoring; Ibuprofen; Lakes; Levofloxacin; Metoprolol; Pharmaceutical Preparations; Risk Assessment; Uganda; Water Pollutants, Chemical | 2024 |
Green UPLC method for estimation of ciprofloxacin, diclofenac sodium, and ibuprofen with application to pharmacokinetic study of human samples.
Topics: Acetonitriles; Chromatography, High Pressure Liquid; Ciprofloxacin; Diclofenac; Humans; Ibuprofen; Reproducibility of Results; Tandem Mass Spectrometry | 2023 |